| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32,480 |
24,524 |
$1.78M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,646 |
11,516 |
$1.12M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,792 |
4,432 |
$345K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,287 |
3,966 |
$304K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,260 |
3,029 |
$255K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,613 |
3,196 |
$237K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,549 |
3,172 |
$110K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,359 |
3,004 |
$94K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,420 |
3,122 |
$86K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
258 |
236 |
$85K |
| 90651 |
|
1,694 |
1,568 |
$79K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,836 |
5,198 |
$73K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
8,398 |
7,598 |
$65K |
| 90670 |
|
2,610 |
2,375 |
$59K |
| 99188 |
|
3,226 |
2,991 |
$59K |
| 99070 |
|
4,051 |
3,005 |
$54K |
| 90698 |
|
3,063 |
2,681 |
$52K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,566 |
1,406 |
$50K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
639 |
580 |
$48K |
| 99215 |
Prolong outpt/office vis |
324 |
297 |
$39K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
368 |
310 |
$38K |
| 90716 |
|
1,631 |
1,487 |
$36K |
| 90680 |
|
2,118 |
1,901 |
$34K |
| 90686 |
|
2,938 |
2,531 |
$31K |
| 90620 |
|
764 |
654 |
$27K |
| 90707 |
|
1,591 |
1,445 |
$26K |
| 90619 |
|
439 |
423 |
$25K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,229 |
2,914 |
$25K |
| 99401 |
|
1,464 |
1,169 |
$24K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
193 |
188 |
$23K |
| 90677 |
|
360 |
316 |
$21K |
| 99173 |
|
9,534 |
8,717 |
$21K |
| 90734 |
|
617 |
549 |
$20K |
| 99177 |
|
4,846 |
4,491 |
$19K |
| 90633 |
|
1,490 |
1,371 |
$19K |
| 90744 |
|
1,643 |
1,460 |
$18K |
| 0001A |
|
538 |
495 |
$18K |
| 92551 |
|
1,955 |
1,720 |
$17K |
| 90671 |
|
166 |
161 |
$17K |
| 96127 |
|
3,556 |
3,316 |
$16K |
| 87807 |
|
1,325 |
1,173 |
$16K |
| 99000 |
|
6,358 |
5,654 |
$15K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
10,240 |
9,118 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
305 |
272 |
$12K |
| 87634 |
|
181 |
156 |
$10K |
| 0002A |
|
246 |
235 |
$9K |
| 90461 |
|
5,410 |
4,815 |
$9K |
| 87631 |
|
109 |
75 |
$8K |
| 90672 |
|
508 |
470 |
$8K |
| 90715 |
|
491 |
440 |
$7K |
| 90688 |
|
520 |
484 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
510 |
437 |
$5K |
| 90696 |
|
403 |
350 |
$5K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
62 |
60 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,513 |
4,939 |
$4K |
| 96160 |
|
1,957 |
1,626 |
$4K |
| 90656 |
|
249 |
248 |
$4K |
| 86580 |
|
486 |
421 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
220 |
173 |
$2K |
| 69210 |
|
62 |
58 |
$2K |
| 94664 |
|
209 |
173 |
$2K |
| 99205 |
Prolong outpt/office vis |
14 |
12 |
$2K |
| 81002 |
|
548 |
479 |
$2K |
| 90685 |
|
125 |
116 |
$1K |
| 0003A |
|
34 |
34 |
$1K |
| 90473 |
|
481 |
444 |
$1K |
| 99384 |
|
14 |
12 |
$786.08 |
| 99051 |
|
108 |
96 |
$761.78 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
12 |
$727.21 |
| 90660 |
|
40 |
39 |
$595.45 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
582 |
516 |
$467.58 |
| A7006 |
Administration set, with small volume filtered pneumatic nebulizer |
122 |
91 |
$445.90 |
| 99495 |
|
14 |
13 |
$240.00 |
| S8101 |
Holding chamber or spacer for use with an inhaler or nebulizer; with mask |
14 |
13 |
$226.35 |
| 90700 |
|
15 |
15 |
$167.71 |
| 99072 |
|
864 |
728 |
$44.50 |
| 96161 |
|
16 |
13 |
$28.93 |